SCHEMBL6201249

SCHEMBL6201249

Cc1cc(NC(=O)NCCN2CCC(Oc3ccccc3C)CC2)c2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 5/20 0.61
ADRA2A P08913 1/20 0.61
DRD2 P14416 1/20 0.61
SLC6A2 P23975 1/20 0.61
HTR2A P28223 1/20 0.61
HTR2C P28335 1/20 0.61
SLC6A4 P31645 1/20 0.61
TMEM97 Q5BJF2 1/20 0.61
SIGMAR1 Q99720 1/20 0.61
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
HTT P42858 3/20 0.45
LMNA P02545 2/20 0.45
USP2 O75604 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 2/20 0.44
IGF1R P08069 2/20 0.44
HTR1A P08908 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6199389 0.92 UTS2R (0.60) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6194791 0.90 UTS2R (0.64) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6199252 0.87 KMT2A (0.50) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4858422 0.85 UTS2R (0.64) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4852043 0.85 UTS2R (0.64) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4862060 0.84 UTS2R (0.68) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4857066 0.84 UTS2R (0.68) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6197148 0.84 UTS2R (0.65) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4861960 0.83 UTS2R (0.60) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL4853518 0.83 UTS2R (0.67) UTS2RADRA2ADRD2SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499607-B1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2005-12-07 EP disclosed